S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
IMRX · Immuneering Corporation Class A
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$3.75
+0.02
(+0.54%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$3.75
$3.73
$3.79
52-WEEK RANGE
$3.75
$3.38
$8.48
What's happening
- IMRX is up 0.54% today, trading at $3.75. — Live quote
- Volume today (30,401) is well below its 3-month average of 892,080. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.27 actual vs. $-0.27 estimated (+1.2%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 4
Buy 8
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (13 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
IMRX
-43.31%
vs S&P 500
-56.09%
1-YEAR RETURN
IMRX
-33.51%
vs S&P 500
-48.07%
6-MONTH RETURN
IMRX
-33.03%
3-MONTH RETURN
IMRX
-16.37%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.27
Est. $-0.27
BEAT +1.2%
2026-04-26 (Q1 2026)
$-0.21
Est. $-0.26
BEAT +18.3%
2026-01-26 (Q4 2025)
$-0.18
Est. $-0.32
BEAT +43.7%
2025-10-26 (Q3 2025)
$-0.38
Est. $-0.40
BEAT +5.0%
Valuation Measures & Ratios
Enterprise Value4$200.6M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)483.94
Price / Book71.69
EV4 / Revenue401.29
EV4 / EBITDA—
Profit Margin-9610.00%
Operating Margin-9778.00%
Return on Equity (ROE8)-27.15%
Return on Assets (ROA9)-25.74%
Avg Volume (3M)892,080
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $318.5M | $337.2M | $274.7M | $120.9M | $55.9M |
| P/E | -5.30 | -5.82 | -4.65 | -2.08 | -0.96 |
| Price/Book | 1.67 | 1.63 | 1.20 | 4.18 | 1.34 |
| EV/EBITDA | -4.32 | -4.78 | -0.78 | — | — |
| ROE | -31.53% | -28.04% | -25.90% | -200.99% | -138.69% |
| ROA | -29.76% | -26.96% | -24.49% | -145.19% | -114.50% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short15,492,438
Change from Prior Settlement-0.37%
% of Float—
Days to Cover (Short Ratio)24.22
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 10-Q, filed 2026-08-05; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -9610.0%. Finnhub fundamentals ↗
- Trailing 52-week price return is -33.5%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on IMRX
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$19.0M | -$15.3M | -$15.4M | -$14.8M | -$15.5M | -$15.3M | -$14.9M | -$15.3M |
| Net income | -$17.3M | -$13.5M | -$15.0M | -$14.4M | -$15.0M | -$14.6M | -$14.1M | -$14.3M |
| EPS (diluted) | $-0.27 | $-0.21 | $-0.38 | $-0.40 | $-0.42 | $-0.49 | $-0.47 | $-0.49 |
| EPS (basic) | $-0.27 | $-0.21 | $-0.38 | $-0.40 | $-0.42 | $-0.49 | $-0.47 | $-0.49 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $202.1M | $214.8M | $232.0M | $241.1M | $40.1M | $50.7M | $52.7M | $68.6M |
| Total liabilities | $11.3M | $8.3M | $13.5M | $13.1M | $11.1M | $8.8M | $11.3M | $10.8M |
| Stockholders' equity | $190.7M | $206.5M | $218.5M | $228.0M | $28.9M | $41.8M | $41.4M | $57.7M |
| Total current assets | $158.0M | $161.4M | $176.2M | $229.1M | $27.7M | $38.2M | $39.6M | $55.3M |
| Total current liabilities | $8.1M | $5.0M | $10.1M | $9.5M | $7.5M | $5.1M | $7.5M | $6.9M |
| Cash & equivalents | $41.3M | $47.3M | $128.6M | $227.6M | $26.4M | $35.9M | $36.1M | $45.2M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Marketable securities (non-current) | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $879.9K | $937.0K | $938.5K | $892.6K | $964.1K | $1.0M | $1.1M | $1.2M |
| Goodwill | $6.7M | $6.7M | $6.7M | $6.7M | $6.7M | $6.7M | $6.7M | $6.7M |
| Intangible assets | $306.5K | $313.8K | $321.1K | $328.5K | $335.8K | $343.1K | $350.4K | $357.7K |
| Other non-current assets | $278.1K | $278.1K | $283.6K | $631.3K | $841.7K | $810.9K | $1.3M | $1.3M |
| Accounts payable | $3.4M | $1.5M | $1.5M | $1.6M | $2.4M | $1.3M | $2.0M | $1.9M |
| Accrued liabilities | $4.1M | $3.1M | $7.8M | $7.5M | $4.5M | $3.4M | $5.0M | $4.6M |
| Other current liabilities | $214.5K | $44.2K | $291.5K | $80.1K | $209.7K | $56.5K | $233.7K | $59.7K |
| Other non-current liabilities | — | — | — | — | — | — | — | — |
| Retained earnings | -$311.1M | -$293.8M | -$280.3M | -$268.7M | -$253.8M | -$239.3M | -$224.3M | -$206.2M |
| Accumulated other comprehensive income (loss) | -$406.2K | -$241.0K | $81.3K | — | — | — | $0 | $7.8K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$16.5M | -$18.4M | -$9.8M | -$12.0M | -$9.4M | -$14.1M | -$14.5M | -$13.5M |
| Investing cash flow | $10.5M | -$63.1M | -$88.7M | -$7.3K | -$2.1K | -$8.9K | $5.5M | -$5.4M |
| Financing cash flow | $24.6K | $180.8K | -$357.5K | $213.2M | -$62.0K | $13.8M | -$41.0K | $4.4M |
| Free cash flow | -$16.5M | -$18.5M | -$10.0M | -$12.0M | -$9.4M | -$14.1M | -$14.5M | -$13.5M |
| Capital expenditures | $27.4K | $79.9K | $123.9K | $7.3K | $2.1K | $8.9K | $9.4K | $5.3K |
| Depreciation & amortization | $84.5K | $81.4K | $239.3K | $78.8K | $84.5K | $85.3K | $265.6K | $88.9K |
| Share-based compensation | $1.6M | $1.6M | $1.6M | $1.5M | $1.5M | $1.7M | $1.7M | $1.6M |
| Deferred income taxes | — | — | — | — | — | — | — | — |
| Change in accounts receivable | — | — | — | — | — | — | $0 | $0 |
| Change in accounts payable | $1.9M | -$89.6K | $73.4K | -$974.9K | $1.2M | -$687.9K | $56.7K | -$679.5K |
| Purchases of investments | $12.0M | $72.0M | $88.6M | $0 | $0 | $0 | $0 | $5.4M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | $0 | $317.0K | $2.1M |
| Gross profit | — | — | $0 | $158.8K | $926.9K |
| Operating income | -$59.4M | -$64.1M | -$58.4M | -$51.7M | -$33.9M |
| Net income | -$56.0M | -$61.0M | -$53.5M | -$50.5M | -$33.5M |
| EPS (diluted) | $-1.27 | $-2.04 | $-1.88 | $-1.91 | $-2.46 |
| EPS (basic) | $-1.27 | $-2.04 | $-1.88 | $-1.91 | $-2.46 |
| Operating margin | — | — | — | -$16.3K | -$1.6K |
| Net margin | — | — | — | -$15.9K | -$1.6K |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $232.0M | $52.7M | $102.6M | $122.4M | $166.7M |
| Total liabilities | $13.5M | $11.3M | $12.0M | $12.5M | $10.7M |
| Stockholders' equity | $218.5M | $41.4M | $90.6M | $109.9M | $156.0M |
| Total current assets | $176.2M | $39.6M | $89.1M | $108.7M | $152.3M |
| Total current liabilities | $10.1M | $7.5M | $7.8M | $8.1M | $5.6M |
| Cash & equivalents | $128.6M | $36.1M | $59.4M | $72.6M | $74.9M |
| Marketable securities (current) | — | — | — | $32.9M | $74.3M |
| Accounts receivable | — | — | $0 | $12.4K | $246.0K |
| Marketable securities (non-current) | — | — | — | — | $996.6K |
| Property, plant & equipment | $938.5K | $1.1M | $1.4M | $1.4M | $807.2K |
| Goodwill | $6.7M | $6.7M | $6.7M | $6.7M | $6.7M |
| Intangible assets | $321.1K | $350.4K | $379.7K | $408.9K | $439.0K |
| Other non-current assets | $283.6K | $1.3M | $1.0M | $743.7K | $102.1K |
| Accounts payable | $1.5M | $2.0M | $2.1M | $3.2M | $1.4M |
| Accrued liabilities | $7.8M | $5.0M | $5.2M | $4.5M | $4.0M |
| Other current liabilities | $291.5K | $233.7K | $259.8K | $19.8K | — |
| Retained earnings | -$280.3M | -$224.3M | -$163.3M | -$109.8M | -$59.3M |
| Accumulated other comprehensive income (loss) | $81.3K | $0 | -$778 | -$30.1K | -$49.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$45.3M | -$55.0M | -$49.0M | -$44.1M | -$30.9M |
| Investing cash flow | -$88.7M | $26.4M | $7.3M | $41.8M | -$75.6M |
| Financing cash flow | $226.6M | $5.3M | $28.4M | $19.0K | $144.3M |
| Free cash flow | -$45.5M | -$55.1M | -$49.3M | -$44.8M | -$30.9M |
| Capital expenditures | $142.2K | $84.9K | $342.7K | $742.5K | $60.8K |
| Depreciation & amortization | $324.5K | $355.8K | $322.8K | — | — |
| Share-based compensation | $6.3M | $6.5M | $5.7M | $4.1M | $1.8M |
| Deferred income taxes | — | — | — | — | -$307.5K |
| Change in accounts receivable | — | $0 | -$12.4K | -$233.6K | -$279.7K |
| Change in accounts payable | -$400.8K | -$112.1K | -$1.1M | $1.8M | -$130.4K |
| Purchases of investments | $88.6M | $5.4M | $44.7M | $50.1M | $75.6M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding IMRX as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-10-01 to 2026-06-23
Recent transactions
- Insiders have net bought 8,435 shares over the last 182 days, across 2 purchases and 0 sales.
- Most recent: Zeskind Benjamin J. (PRESIDENT AND CEO) — Open market purchase of 2,400 shares on 2026-06-23.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)8,435 sh(2 txns)
Sales (open market)0 sh(0 txns)
Net Shares+8,435
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Zeskind Benjamin J. | PRESIDENT AND CEO | Open market purchase | 2026-06-23 | 2,400 |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Open market purchase | 2026-06-15 | 6,035 |
| Neufeld Leah R | CHIEF PEOPLE OFFICER | Grant / award | 2026-03-13 | 3,628 |
| Brakewood Harold Eugene | Chief Business Officer | Open market purchase | 2026-01-16 | 5,250 |
| Schall Thomas J. | Director | Open market purchase | 2026-01-15 | 21,645 |
| Feinberg Peter | Director | Open market purchase | 2026-01-12 | 20,000 |
| Morales Mallory | Chief Accounting Officer | Open market purchase | 2025-10-01 | 300 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-23 | Zeskind Benjamin J. | PRESIDENT AND CEO | Open market purchase | 2,400 | $4.56 |
| 2026-06-15 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Open market purchase | 6,035 | $4.15 |
| 2026-03-13 | Neufeld Leah R | CHIEF PEOPLE OFFICER | Grant / award | 3,628 | $4.29 |
| 2026-01-16 | Brakewood Harold Eugene | Chief Business Officer | Open market purchase | 5,250 | $4.76 |
| 2026-01-15 | Schall Thomas J. | Director | Open market purchase | 21,645 | $4.67 |
| 2026-01-15 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Open market purchase | 2,298 | $4.57 |
| 2026-01-13 | Neufeld Leah R | CHIEF PEOPLE OFFICER | Open market purchase | 2,626 | $4.15 |
| 2026-01-12 | Feinberg Peter | Director | Open market purchase | 20,000 | $4.35 |
| 2025-10-03 | Feinberg Peter | Director | Open market purchase | 7,500 | $6.67 |
| 2025-10-01 | Morales Mallory | Chief Accounting Officer | Open market purchase | 300 | $6.39 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 04:24 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-07-17 | 4 | 2026-07-16 | View on SEC.gov → |
| 2026-06-24 | 4 | 2026-06-23 | View on SEC.gov → |
| 2026-06-16 | 4 | 2026-06-15 | View on SEC.gov → |
| 2026-06-15 | 8-K | 2026-06-11 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-11 | 8-K | 2026-06-11 | View on SEC.gov → |
Recent news
Headlines about IMRX (Immuneering Corporation Class A). Links open the publisher — we don’t host full articles.
-
BNL,NTHI,ATLO,IMRX,OPAL,VSH,SDHC,PEB,INNV,NEWT,GRNT,MTDR,ABR,LUCK,GROV,RLMD,DOC,BUSE,IRIX,BLNE | Stock Prices | Quote Comparison - Yahoo Finance
Yahoo! Finance Canada · 2026-10-22 -
BNL,NTHI,IMRX,ATLO,OPAL,SDHC,VSH,PEB,INNV,GRNT,NEWT,MTDR,ABR,LUCK,GROV,RLMD,DOC,BUSE,IRIX,BLNE | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
BNL,NTHI,IMRX,ATLO,OPAL,SDHC,VSH,PEB,INNV,GRNT,NEWT,MTDR,ABR,LUCK,GROV,RLMD,DOC,IRIX,BUSE,BLNE | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
BNL,NTHI,IMRX,ATLO,OPAL,VSH,SDHC,PEB,INNV,GRNT,NEWT,MTDR,ABR,LUCK,GROV,RLMD,BUSE,IRIX,HURC,BLNE | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
BNL,NTHI,ATLO,IMRX,OPAL,VSH,SDHC,PEB,INNV,GRNT,NEWT,MTDR,ABR,LUCK,GROV,RLMD,DOC,BUSE,IRIX,BLNE | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
BNL,NTHI,IMRX,ATLO,OPAL,SDHC,VSH,PEB,INNV,NEWT,GRNT,ABR,MTDR,LUCK,GROV,RLMD,DOC,IRIX,BUSE,BLNE | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
BNL,NTHI,ATLO,IMRX,OPAL,SDHC,VSH,PEB,INNV,GRNT,NEWT,MTDR,ABR,LUCK,GROV,RLMD,IRIX,BUSE,HURC,BLNE | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-20 -
EG,AMN,PGY,HLF,BSBK,IMRX,LCNB,CRMT,ORN,MRBK,FRST,TISI,GRNT,TPL,OVLY,GEF-B,RVSB,NBBK,HBT | Stock Prices | Quote Comparison - Yahoo Finance
Yahoo! Finance Canada · 2026-10-20
No headlines in this category right now — try “All”.